Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis

Timothy N. Hembree, DO, PhD, Jamie K. Teer, PhD, Ardeshir Hakam, MD, and Alberto A. Chiappori, MD


Cancer Control. 2016;23(1):61-66. 

In This Article


Given the genetic heterogeneity reported here, knowledge of the mutational profile of any given tumor could be linked to a differential prognosis or therapeutic response, and mutation profiles described here and elsewhere suggest new therapeutic options.[10,18] Potential exists for personalized understanding and treatment options for patients with uterine carcinosarcoma; however, given the rarity of the disease, collaborative efforts will be critical to understanding the relationships between molecular alterations and clinical features.